SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 209 filers reported holding SAGE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,977 | -57.9% | 100 | 0.0% | 0.00% | – |
| Q2 2023 | $4,697 | +11.3% | 100 | 0.0% | 0.00% | – |
| Q1 2023 | $4,219 | +13.4% | 100 | 0.0% | 0.00% | – |
| Q4 2022 | $3,722 | -5.9% | 100 | 0.0% | 0.00% | – |
| Q3 2022 | $3,957 | +22.7% | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $3,225 | -12.8% | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $3,700 | -12.3% | 100 | 0.0% | 0.00% | – |
| Q4 2021 | $4,221 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 312,000 | $29,886,000 | 5.11% |
| DAFNA Capital Management LLC | 104,306 | $9,991,000 | 4.97% |
| Palo Alto Investors LP | 850,977 | $81,515,000 | 4.34% |
| BB BIOTECH AG | 1,375,229 | $131,733,000 | 4.22% |
| Eventide Asset Management | 936,000 | $89,659,000 | 3.97% |
| TRV GP II, LLC | 37,362 | $3,579,000 | 3.56% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 146,179 | $14,002,000 | 2.11% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 111,908 | $10,720,000 | 2.06% |
| OAK RIDGE INVESTMENTS LLC | 231,483 | $22,174,000 | 1.60% |
| Rhenman & Partners Asset Management AB | 137,339 | $13,156,000 | 1.50% |